Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan
VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple...
KPM Analytics Secures Legal Victory in Trade Secret Misappropriation Case
Court awards $10M to KPM Analytics in Trade Secret Theft and Tortious Interference Case, Reinforcing Commitment to Innovation and Fair Competition. WESTBOROUGH, Mass., March 3, 2025 /PRNewswire/ -- KPM Analytics, a global leader in analytical...
CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
SHANGHAI, March 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the Center for...
Yuchai Enters Into Strategic Agreement in Vietnam
SINGAPORE, Feb. 20, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery...
Thailand BOI Approves Investments Worth A Total of US$5 Billion, Including TikTok's Data Hosting Project; Green Lights Revised Incentives for the Bioeconomy
BANGKOK, Jan. 29, 2025 /PRNewswire/ -- The Thailand Board of Investment (BOI) today approved investment privileges for projects worth a combined 170.5 billion baht (ca. US$5 Billion) in value, including a digital infrastructure project by leading...
Grant of Restricted Shares Under Big Tree Cloud Holdings Limited 2024 Equity Incentive Plan
SHENZHEN, China, Jan. 25, 2025 /PRNewswire/ -- Big Tree Cloud Holdings Limited ("Big Tree Cloud" or the "Company") (NASDAQ: DSY) (NASDAQ: DSYWW), a company devoted to the development, production, and sales of personal care products and other...
Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer
SYDNEY, Jan. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and...
Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers
HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement with ArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
The World's Most (and Least) Powerful Passports in 2025
LONDON, Jan. 8, 2025 /PRNewswire/ -- Singapore reclaims its crown as the most powerful passport in the world with visa-free access to 195 out of 227 destinations worldwide, leaving Japan as runner-up with a score of 193, according to the 2025 Henley...